Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Lindsay Corp
LNN
$1.18B
| $536K | ﹤0.01% |
6,521
-1,903
| -23% | -$148K |
|
|
GGT
3952
Gabelli Multimedia Trust
GGT
$174M
| $535K | ﹤0.01% |
47,051
+13,631
| +41% | +$139K |
|
3953
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$438M
| $535K | ﹤0.01% |
6,940
+363
| +6% | +$28K |
|
|
SGEN
3954
DELISTED
Seagen Inc. Common Stock
SGEN
| $535K | ﹤0.01% |
13,694
+3,016
| +28% | +$123K |
|
|
CFN
3955
CALL
DELISTED
CAREFUSION CORPORATION
CFN
| $535K | ﹤0.01% |
13,700
-534,100
| -97% | -$20.8M |
|
3956
Radware
RDWR
$1.19B
| $534K | ﹤0.01% |
+31,433
| New | +$496K |
|
3957
PUT
Progressive
PGR
$125B
| $532K | ﹤0.01% |
19,700
-61,100
| -76% | -$1.65M |
|
|
JASO
3958
CALL
DELISTED
JA Solar Holdings, Co., Ltd
JASO
| $532K | ﹤0.01% |
59,100
-45,000
| -43% | -$453K |
|
|
UIL
3959
DELISTED
UIL HOLDINGS
UIL
| $531K | ﹤0.01% |
14,001
-13,881
| -50% | -$526K |
|
|
PMT
3960
PennyMac Mortgage Investment
PMT
$842M
| $530K | ﹤0.01% |
24,083
-220,705
| -90% | -$4.99M |
|
|
QLGC
3961
DELISTED
QLOGIC CORP
QLGC
| $530K | ﹤0.01% |
48,259
-216,475
| -82% | -$2.52M |
|
3962
Fair Isaac
FICO
$22.5B
| $529K | ﹤0.01% |
8,550
+4,163
| +95% | +$240K |
|
3963
VanEck Indonesia Index ETF
IDX
$37.3M
| $529K | ﹤0.01% |
25,168
-21,629
| -46% | -$496K |
|
|
KAMN
3964
DELISTED
Kaman Corp
KAMN
| $529K | ﹤0.01% |
13,539
-8
| -0.1% | -$306 |
|
|
OREX
3965
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $529K | ﹤0.01% |
10,588
+3,789
| +56% | +$213K |
|
3966
Noodles & Co
NDLS
$107M
| $528K | ﹤0.01% |
1,885
+1,581
| +520% | +$525K |
|
3967
PUT
Telefônica Brasil
VIV
$19.2B
| $528K | ﹤0.01% |
27,800
+19,800
| +248% | +$402K |
|
3968
PUT
iShares MSCI Italy ETF
EWI
$1.07B
| $527K | ﹤0.01% |
17,550
-15,100
| -46% | -$458K |
|
3969
CALL
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $527K | ﹤0.01% |
3,900
-3,500
| -47% | -$454K |
|
|
JLA
3970
DELISTED
NUVEEN EQUITY PREMIUM ADVANTAGE FUND
JLA
| $527K | ﹤0.01% |
43,883
+7,086
| +19% | +$88K |
|
3971
PUT
Popular Inc
BPOP
$11.1B
| $526K | ﹤0.01% |
18,800
-15,000
| -44% | -$405K |
|
3972
PUT
Oshkosh
OSK
$9.59B
| $525K | ﹤0.01% |
10,500
-2,600
| -20% | -$130K |
|
3973
Natural Resource Partners
NRP
$1.42B
| $523K | ﹤0.01% |
2,754
+546
| +25% | +$109K |
|
3974
OneMain Financial
OMF
$7.47B
| $523K | ﹤0.01% |
+20,898
| New | +$447K |
|
3975
First Commonwealth Financial
FCF
$2.17B
| $522K | ﹤0.01% |
65,343
-4,340
| -6% | -$37.4K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.